Concepedia

John Rinehart

JR

Statistics

Publications

4

Citations

179

H-Index

4

Active since

1976

Affiliations

Mayo Clinic in Florida(Current)

Pfizer (United States)

John Rinehart is an author at Mayo Clinic in Florida specializing in tumor biology, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

1976–2007

4

Publications

4

A phase 1–2 clinical study of a second generation oral MEK inhibitor, PD 0325901 in patients with advanced cancer

Patricia LoRusso, S Krishnamurthi, John Rinehart et al. · Journal of Clinical Oncology · 2005 · 89 citations

, , +18

Evaluation of Two Phenanthrenemethanols for Antimalarial Activity in Man: WR 122,455 and WR 171,669

John Rinehart, John Arnold, Craig J. Canfield · American Journal of Tropical Medicine and Hygiene · 1976 · 45 citations

Pharmacokinetics (PK) and pharmacodynamics (PD) of PD 0325901, a second generation MEK inhibitor after multiple oral doses of PD 0325901 to advanced cancer patients

Sujatha Menon, Lloyd R. Whitfield, Seth Sadis et al. · Journal of Clinical Oncology · 2005 · 28 citations

Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer

Patricia LoRusso, Smitha Krishnamurthi, John Rinehart et al. · Molecular Cancer Therapeutics · 2007 · 17 citations

, , +11

Rows per page

1–4 of 4